As a systemic marker and regulator of chronic inflammation leading to tissue fibrogenesis, galectin-3 may reflect increased cardiovascular risk in RA resulting from impaired muscle remodeling. The gene discussed is LGALS3; the disease is rheumatoid arthritis.